Joseph CPA - Johnson Johnson Ex CFO
| JNJ Stock | EUR 142.26 0.26 0.18% |
Insider
Joseph CPA is Ex CFO of Johnson Johnson
| Age | 56 |
| Phone | 732 524 0400 |
| Web | https://www.jnj.com |
Johnson Johnson Management Efficiency
The company has return on total asset (ROA) of 0.0871 % which means that it generated a profit of $0.0871 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2379 %, meaning that it generated $0.2379 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Pascale Schmidt | Roche Holding Ltd | 50 | |
| Johannes MD | Roche Holding Ltd | 66 | |
| Esteban Santos | Amgen Inc | 55 | |
| Mike Zahigian | Amgen Inc | N/A | |
| Linda Louie | Amgen Inc | N/A | |
| Jennifer Mauer | Merck Co | N/A | |
| BerndPeter Bier | Bayer Aktiengesellschaft | 56 | |
| Rodrigo Santos | Bayer AG NA | 50 | |
| Frank Lohner | Amgen Inc | 54 | |
| BerndPeter Bier | Bayer AG NA | 56 | |
| Catherine Levitt | Astellas Pharma | N/A | |
| Yoshitsugu Shitaka | Astellas Pharma | N/A | |
| Bruno Eschli | Roche Holding Ltd | N/A | |
| Heiko Schipper | Bayer AG NA | 54 | |
| Kenji Yasukawa | Astellas Pharma | 63 | |
| Kenneth Frazier | Merck Co | 67 | |
| Susan Esq | Biogen Inc | 66 | |
| Michael Hencke | Biogen Inc | N/A | |
| Rodrigo Santos | Bayer Aktiengesellschaft | 50 | |
| Robin Kramer | Biogen Inc | 57 | |
| Katsuyoshi Sugita | Astellas Pharma | N/A | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0871 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk Brinckman, Chief Officer | ||
| Robert Decker, Controller Officer | ||
| Alex Gorsky, Chairman of the Board, CEO | ||
| Jessica Moore, VP Relations | ||
| Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
| Joseph CPA, Ex CFO | ||
| James Swanson, Ex Officer | ||
| Elizabeth Forminard, Exec Counsel | ||
| Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
| Peter Fasolo, Vice President - Global Human Resources |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0871 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 443.95 B | |||
| Shares Outstanding | 2.6 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 71.60 % | |||
| Price To Earning | 29.33 X | |||
| Price To Book | 6.28 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .